Literature DB >> 30835883

PD-L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's sarcoma.

G Genovese1,2, L Venegoni2, D Fanoni2, A Tourlaki1, L Brambilla1, E Berti1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30835883     DOI： 10.1111/jdv.15543

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

Review 1.  Current and Future Tools for Diagnosis of Kaposi's Sarcoma.

Authors:  Nicolas Dupin; Aude Jary; Samia Boussouar; Charlotte Syrykh; Amir Gandjbakhche; Sébastien Bergeret; Romain Palich
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

Review 2.  Therapeutic Perspectives in the Systemic Treatment of Kaposi's Sarcoma.

Authors:  Marc-Antoine Valantin; Léna Royston; Maxime Hentzien; Aude Jary; Alain Makinson; Marianne Veyri; Sylvie Ronot-Bregigeon; Stéphane Isnard; Romain Palich; Jean-Pierre Routy
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

3.  COVID-19 Vaccination in Patients with Classic Kaposi's Sarcoma.

Authors:  Alice Indini; Athanasia Tourlaki; Francesco Grossi; Donatella Gambini; Lucia Brambilla
Journal:  Vaccines (Basel)       Date:  2021-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.